Home > Insider Trading > Filing (0001127602-22-008251)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Bausch Health Companies Inc.	BHC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1543795	Robert Spurr	C/O Bausch Health Companies, Inc. 400 Somerset Corporate Blvd. Bridgewater NJ 08807	U.s. President-Pharma Business	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, No Par Value	Disposition	2022-03-02	1,595	$23.37	65,394	No	4	S	Direct
Common Shares, No Par Value	Acquisiton	2022-03-02	35,627	$24.17	101,021	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares, No Par Value	Non-Qualified Stock Options (right to purchase)	Acquisiton	2022-03-02	131,910	$0.00	131,910	$24.17

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
131,910		2032-03-02	No	4	A	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.
Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
The options vest in equal installments on each of the first three anniversaries of the date of grant.